CVE:EPI - ESSA Pharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
C$4.10 -0.10 (-2.38 %)
(As of 08/22/2018 01:38 AM ET)
Previous CloseC$4.20
Today's RangeC$4.10 - C$4.10
52-Week RangeC$3.01 - C$7.15
Volume150 shs
Average Volume11,327 shs
Market CapitalizationC$7.70 million
P/E RatioN/A
Dividend Yield0.83%
Beta0.51
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel therapeutics for the treatment of prostate cancer. It is developing EPI-506 that is in Phase 1/2 clinical trials for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

Receive EPI News and Ratings via Email

Sign-up to receive the latest news and ratings for EPI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange CVE
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
SymbolCVE:EPI
CUSIPN/A
Phone+1-778-3310962

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on Assets-189.16%

Miscellaneous

EmployeesN/A
Outstanding Shares5,776,000
Market CapC$7.70 million

ESSA Pharma (CVE:EPI) Frequently Asked Questions

What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EPI."

How were ESSA Pharma's earnings last quarter?

ESSA Pharma Inc (CVE:EPI) issued its earnings results on Tuesday, August, 14th. The company reported ($0.65) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.95) by $0.30. View ESSA Pharma's Earnings History.

When is ESSA Pharma's next earnings date?

ESSA Pharma is scheduled to release their next quarterly earnings announcement on Monday, December, 10th 2018. View Earnings Estimates for ESSA Pharma.

What is the consensus analysts' recommendation for ESSA Pharma?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ESSA Pharma in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for ESSA Pharma.

Who are some of ESSA Pharma's key competitors?

Who are ESSA Pharma's key executives?

ESSA Pharma's management team includes the folowing people:
  • Dr. David Ross Parkinson, Pres, CEO & Director (Age 68)
  • Mr. David S. Wood, Chief Financial Officer (Age 61)
  • Mr. Peter A. Virsik, Exec. VP & COO (Age 47)
  • Dr. Raymond Andersen, CTO, Sec. & Director (Age 71)
  • Dr. Marianne D. Sadar, Chief Scientific Officer & Director (Age 57)

Has ESSA Pharma been receiving favorable news coverage?

Media coverage about EPI stock has trended somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm scores the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. ESSA Pharma earned a coverage optimism score of 0.10 on Accern's scale. They also gave news stories about the company an impact score of 46.56 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days. View Recent Headlines for ESSA Pharma.

How do I buy shares of ESSA Pharma?

Shares of EPI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is ESSA Pharma's stock price today?

One share of EPI stock can currently be purchased for approximately C$4.10.

How big of a company is ESSA Pharma?

ESSA Pharma has a market capitalization of C$7.70 million.

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 Broadway W Suite 720, VANCOUVER, BC V5Z 1K5, Canada. The company can be reached via phone at +1-778-3310962.


MarketBeat Community Rating for ESSA Pharma (CVE EPI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  26 (Vote Outperform)
Underperform Votes:  25 (Vote Underperform)
Total Votes:  51
MarketBeat's community ratings are surveys of what our community members think about ESSA Pharma and other stocks. Vote "Outperform" if you believe EPI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EPI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel